MedPath

Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy

Phase 3
Completed
Conditions
Ovarian Cancer
Registration Number
NCT00006453
Lead Sponsor
AGO Study Group
Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known if carboplatin is more effective with or without gemcitabine for ovarian epithelial cancer.

PURPOSE: Randomized phase III trial to compare the effectiveness of carboplatin with or without gemcitabine in treating patients who have advanced ovarian epithelial cancer that has not responded to previous chemotherapy.

Detailed Description

OBJECTIVES:

* Compare time to progression in patients with advanced ovarian epithelial carcinoma who failed prior first-line platinum-based therapy when treated with carboplatin with or without gemcitabine.

* Compare response rate, duration of response, and survival time of patients treated with these regimens.

* Compare the toxicity of these treatment regimens in these patients.

* Compare quality of life of patients treated with these regimens.

OUTLINE: This is a randomized, open-label, multicenter study. Patients are stratified according to progression-free time (6-12 months vs more than 12 months), type of prior first-line therapy, and bidimensionally measurable disease (yes vs no). Patients are randomized to one of two treatment arms.

* Arm I: Patients receive carboplatin IV over 30-60 minutes on day 1 and gemcitabine IV over 30-60 minutes on days 1 and 8.

* Arm II: Patients receive carboplatin IV as in arm I. Treatment in both arms repeats every 3 weeks for up to 6-8 courses in the absence of disease progression or unacceptable toxicity.

Quality of life is assessed at baseline, before each subsequent chemotherapy course, and at 50 days after study.

Patients are followed at 50 days, every 2 months for 1 year, and then every 3 months for 1 year.

PROJECTED ACCRUAL: A total of 350 patients will be accrued for this study.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (74)

Penticton Regional Hospital

🇨🇦

Penticton, British Columbia, Canada

Prostate Centre at Vancouver General Hospital

🇨🇦

Vancouver, British Columbia, Canada

St. Paul's Hospital - Vancouver

🇨🇦

Vancouver, British Columbia, Canada

G. Steinhoff Clinical Research

🇨🇦

Victoria, British Columbia, Canada

William Osler Health Centre

🇨🇦

Brampton, Ontario, Canada

British Columbia Cancer Agency - Vancouver Island Cancer Centre

🇨🇦

Victoria, British Columbia, Canada

Saint John Regional Hospital

🇨🇦

Saint John, New Brunswick, Canada

York County Hospital

🇨🇦

Newmarket, Ontario, Canada

Credit Valley Hospital

🇨🇦

Mississauga, Ontario, Canada

St. Michael's Hospital - Toronto

🇨🇦

Toronto, Ontario, Canada

Allan Blair Cancer Centre

🇨🇦

Regina, Saskatchewan, Canada

Toronto Sunnybrook Regional Cancer Centre

🇨🇦

Toronto, Ontario, Canada

Saint Joseph's Health Centre - Toronto

🇨🇦

Toronto, Ontario, Canada

Humber River Regional Hospital

🇨🇦

Weston, Ontario, Canada

Cancer Care Ontario - Windsor Regional Cancer Centre

🇨🇦

Windsor, Ontario, Canada

Complexe Hospitalier de la Sagamie

🇨🇦

Chicoutimi, Quebec, Canada

CHUS-Hopital Fleurimont

🇨🇦

Fleurimont, Quebec, Canada

Centre Hospitalier Regional de Lanaudiere

🇨🇦

Joliette, Quebec, Canada

Hopital Charles Lemoyne

🇨🇦

Greenfield Park, Quebec, Canada

L'Hotel Dieu de Levis

🇨🇦

Levis, Quebec, Canada

Maisonneuve-Rosemont Hospital

🇨🇦

Montreal, Quebec, Canada

Centre Hospitalier de l'Universite' de Montreal

🇨🇦

Montreal, Quebec, Canada

Trillium Health Centre

🇨🇦

Mississauga, Ontario, Canada

Cancer Care Ontario-Hamilton Regional Cancer Centre

🇨🇦

Hamilton, Ontario, Canada

Grand River Regional Cancer Centre

🇨🇦

Kitchner, Ontario, Canada

Doctor Leon Richard Oncology Centre

🇨🇦

Moncton, New Brunswick, Canada

Moncton Hospital

🇨🇦

Moncton, New Brunswick, Canada

Lethbridge Cancer Clinic

🇨🇦

Lethbridge, Alberta, Canada

British Columbia Cancer Agency - Centre for the Southern Interior

🇨🇦

Kelowna, British Columbia, Canada

British Columbia Cancer Agency - Fraser Valley Cancer Centre

🇨🇦

Surrey, British Columbia, Canada

St. Mary's/Duluth Clinic Health System

🇺🇸

Duluth, Minnesota, United States

Cancer Care Ontario-London Regional Cancer Centre

🇨🇦

London, Ontario, Canada

Royal Victoria Hospital, Barrie

🇨🇦

Barrie, Ontario, Canada

Hamilton and Disrict Urology Association

🇨🇦

Hamilton, Ontario, Canada

Newfoundland Cancer Treatment and Research Foundation

🇨🇦

St. Johns, Newfoundland and Labrador, Canada

North York General Hospital, Ontario

🇨🇦

North York, Ontario, Canada

Male Health Centre/CMX Research Inc.

🇨🇦

Oakville, Ontario, Canada

Nova Scotia Cancer Centre

🇨🇦

Halifax, Nova Scotia, Canada

Cape Breton Cancer Centre

🇨🇦

Sydney, Nova Scotia, Canada

Northeastern Ontario Regional Cancer Centre, Sudbury

🇨🇦

Sudbury, Ontario, Canada

Algoma District Medical Group

🇨🇦

Sault Sainte Marie, Ontario, Canada

Ottawa Regional Cancer Centre

🇨🇦

Ottawa, Ontario, Canada

Lakeridge Health Oshawa

🇨🇦

Oshawa, Ontario, Canada

Peterborough Oncology Clinic

🇨🇦

Peterborough, Ontario, Canada

Mount Sinai Hospital - Toronto

🇨🇦

Toronto, Ontario, Canada

Toronto General Hospital

🇨🇦

Toronto, Ontario, Canada

Princess Margaret Hospital

🇨🇦

Toronto, Ontario, Canada

Queen Elizabeth Hospital, PEI

🇨🇦

Charlottetown, Prince Edward Island, Canada

Hotel Dieu de Montreal

🇨🇦

Montreal, Quebec, Canada

Centre Hospitalier de l'Universite de Montreal

🇨🇦

Montreal, Quebec, Canada

McGill University

🇨🇦

Montreal, Quebec, Canada

Hopital Sainte Justine

🇨🇦

Montreal, Quebec, Canada

Kells Medical Research Group Inc.

🇨🇦

Pointe Claire, Quebec, Canada

Centre Hospitalier Universitaire de Quebec

🇨🇦

Quebec City, Quebec, Canada

Lions Gate Hospital

🇨🇦

North Vancouver, Canada

Hopital Du Sacre-Coeur de Montreal

🇨🇦

Montreal, Quebec, Canada

Saskatoon Cancer Centre

🇨🇦

Saskatoon, Saskatchewan, Canada

Toronto Urology Study Group

🇨🇦

Toronto, Canada

Tom Baker Cancer Center - Calgary

🇨🇦

Calgary, Alberta, Canada

Nanaimo Cancer Clinic

🇨🇦

Nanaimo, British Columbia, Canada

Cross Cancer Institute

🇨🇦

Edmonton, Alberta, Canada

British Columbia Cancer Agency

🇨🇦

Vancouver, British Columbia, Canada

CancerCare Manitoba

🇨🇦

Winnipeg, Manitoba, Canada

London Health Sciences Centre

🇨🇦

London, Ontario, Canada

Centre Hospitalier Regional de Rimouski

🇨🇦

Rimouski, Quebec, Canada

L'Hopital Laval

🇨🇦

Ste-Foy, Quebec, Canada

Hopital du Saint-Sacrament, Quebec

🇨🇦

Quebec City, Quebec, Canada

Women's College Campus, Sunnybrook and Women's College Health Science Center

🇨🇦

Toronto, Ontario, Canada

Scarborough Hospital - General Site

🇨🇦

Scarborough, Ontario, Canada

Northwestern Ontario Regional Cancer Centre, Thunder Bay

🇨🇦

Thunder Bay, Ontario, Canada

Toronto East General Hospital

🇨🇦

Toronto, Ontario, Canada

Kingston Regional Cancer Centre

🇨🇦

Kingston, Ontario, Canada

Markham Stouffville Hospital

🇨🇦

Markham, Ontario, Canada

Hotel Dieu Health Sciences Hospital - Niagara

🇨🇦

St. Catharines, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath